We are live on ! Find out more

24 hedge funds and large institutions have $1.55M invested in Imunon in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

20% more funds holding

Funds holding: 2024 (+4)

0% less ownership

Funds ownership: 0.03%0.03% (-0%)

53% less capital invested

Capital invested by funds: $3.27M → $1.55M (-$1.72M)

96% less call options, than puts

Call options by funds: $10K | Put options by funds: $274K

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
3
Closed
1
Calls
$10K
Puts
$274K
Net Calls
-$264K
Net Calls Change
-$211K

IMNN Hedge Fund Activity: Q4 2018 in Review

24 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2018, worth a combined $1.55M — down 53% from $3.27M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new IMNN positions and 1 closed out — a net gain of 4 holders — while 5 added to existing stakes and 3 trimmed.

The largest buyer was Group One Trading, opening a new position worth an estimated $118K. The largest seller was Vanguard Group, cutting an estimated $524K.

  • 24 institutional investors held Imunon (IMNN) as of Q4 2018, up from 20 in Q3 2018.
  • Funds reported $1.55M of Imunon stock for Q4 2018, down 53% quarter-over-quarter.
  • 5 funds opened new Imunon positions in Q4 2018 and 1 closed out, a net change of +4 holders.
  • The largest Imunon buyer in Q4 2018 was Group One Trading, an estimated $118K added.
  • The largest Imunon seller in Q4 2018 was Vanguard Group, an estimated $524K sold.

Based on aggregated 13F filings for Q4 2018.